Perrett Laver :: Insights

A WAKE-UP CALL: Cross-Sectoral Diversity and Board Room Equality

In March 2023, Perrett Laver and the Berlin Research 50 (BR50) joined forces and launched their cooperation at EMST Berlin, led by Dr. Nicole Shea, our Managing Partner for Germany, and Dr. Anja Sommerfeld, BR50.

Prof Wiebke Arlt appointed Director of MRC London Institute of Medical Sciences

The renowned clinical endocrinologist will join MRC LMS from the University of Birmingham on 1 January 2023 Professor Wiebke Arlt has been appointed Director of the Imperial College London-hosted Medical Research Council London Institute of Medical Sciences (LMS). She will formally take up her new position from 1 January 2023. In addition, Professor Arlt will become Head of Imperial’s Institute of Clinical Sciences, one of the eight academic departments that make up the College’s Faculty of Medicine.

Matthew Wallenstein announced as Chief Soil Scientist with Syngenta

Matthew Wallenstein will be starting a new role as Chief Soil Scientist with Syngenta on April 18

Meet the Leaders: In Conversation with Annelien Bredenoord

Annelien Bredenoord is a professor of Biomedical Ethics and the current Rector Magnificus at Erasmus University Rotterdam (EUR). As a leader and pioneer in her field, her research group centres on ethical and social issues in modern technology such as artificial intelligence, tissue engineering and stem cell research. We sat down with Annelien to discuss her new role as Rector Magnificus, the latest research in her field, the value of interdisciplinary education to solve societal issues and what advice she would give to women in STEM.

Perrett Laver appoints six new Partners

Sir Patrick Vallance to become the Natural History Museum's next Chairman of the Board of Trustees

The Government's Chief Scientific Adviser, Sir Patrick Vallance, will become the next Chairman of the Board of Trustees of the Museum.

Meet the Leaders: In Conversation with Charmaine Griffiths

Dr Charmaine Griffiths is the Chief Executive of the British Heart Foundation (BHF), the largest independent funder of cardiovascular research in the UK, and one of the largest in the world. She has a lifelong passion for improving human health and has spent her career finding ways to deliver positive impact for patients and their families. We sat down with Charmaine to discuss her role at the BHF, how the organisation responded to the challenges of the pandemic and what advice she’d give to the leaders of the future.

Andrew Mackintosh appointed as new Chair of UK Innovation and Science Seed Fund Advisory Board

The UK Innovation and Science Seed Fund (UKI2S) is pleased to announce the appointment of Dr Andrew Mackintosh as the new Chair of its Advisory Board. UKI2S enables and accelerates the commercial success of innovative companies from the UK’s publicly funded research base ranging from nuclear fusion to agrifoods and from synthetic biology to AI and space technologies.

Insights / category: Academic Medicine and Health Sciences